FINWIRES · TerminalLIVE
FINWIRES

研究快讯:Healthpeak 第一季度:8.8 亿美元 Janus Living 分拆上市释放价值

By

-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师总结如下:DOC公布了2026年第一季度业绩,其中营收同比增长7.1%至7.53亿美元,租赁收入为7.39亿美元(+7.5%),超出市场预期4600万美元;尽管每股FFO从0.46美元降至0.45美元,但仍超出预期0.02美元。Janus Living成功上市,募集资金8.8亿美元,打造了一个市值达69亿美元的养老地产平台,验证了管理层的价值释放策略,而DOC仍持有81.6%的股份。更新后的2026年业绩指引反映了IPO的影响,每股收益上调至0.46-0.50美元,而由于管理费收入减少,FFO下调至1.68-1.72美元。同店净营业收入持平,老年住宅业务的强劲增长(+13.8%)被实验室业务的疲软表现(-7.2%)所抵消。入住率持续承压,实验室业务同比下降740个基点至90.4%,门诊医疗业务下降70个基点至91.8%。DOC回购了1亿美元的股票。我们认为门诊医疗业务的入住率将会改善,但预计实验室业务的空置率将在2026年第三季度之前持续上升。我们认为,生物技术业务持续面临的融资挑战将限制实验室业务在2027年上半年的增长空间。

Related Articles

Asia

Anteris Technologies Enrolls First US Patients in PARADIGM Trial; Shares Up 6%

Anteris Technologies (ASX:AVR) has enrolled and successfully treated the first US patients in its PARADIGM global pivotal trial of the DurAVR transcatheter heart valve for severe calcific aortic stenosis, according to a Wednesday Australian bourse filing.The procedures were carried out at Montefiore Medical Center in New York, the filing added.The company's shares rose 6% in recent Wednesday trade.

$ASX:AVR
Research

Research Alert: CFRA Maintains Hold Rating On Shares Of Ballard Power System Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price from CAD4.20 to CAD6.40, applying a price-to-sales multiple of 13x our 2026 sales-per-share view (CAD0.49 using a USD/CAD exchange rate of 0.73x). We adjust our 2026 loss per share (LPS) estimate to -USD0.19 from -USD0.23 and our 2027 LPS view to -USD0.11 from -USD0.15. BLDP reported Q1 2026 revenue of USD19.4M, up 26% Y/Y, driven by strong growth in rail (up 4,472% to USD5.1M) and stationary power (up 775% to USD5.2M), though Bus revenue declined 46% to USD6.8M due to delivery timing and EU funding delays. Q1 results showed encouraging metrics, and we see potential upside from major design wins with Wrightbus and Solaris for next-generation hydrogen bus platforms and a multiyear 50 MW agreement with New Flyer. However, its declining backlog remains a concern. The 12-month order book declined 2% to USD52.8M, while the total backlog fell 5% to USD112.9M. We applaud improving gross margin trends, reflecting successful execution of its cost reduction initiatives.

$BLDP
Research

Research Alert: CFRA Maintains Hold Rating On Shares Of Ballard Power System Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price from $3.00 to $4.70, applying a price-to-sales multiple of 13x our 2026 sales-per-share view of $0.36. We adjust our 2026 loss per share (LPS) estimate to -$0.19 from -$0.23 and our 2027 LPS view to -$0.11 from -$0.15. BLDP reported Q1 2026 revenue of $19.4M, up 26% Y/Y, driven by strong growth in rail (up 4,472% to $5.1M) and stationary power (up 775% to $5.2M), though Bus revenue declined 46% to $6.8M due to delivery timing and EU funding delays. Q1 results showed encouraging metrics, and we see potential upside from major design wins with Wrightbus and Solaris for next-generation hydrogen bus platforms and a multiyear 50 MW agreement with New Flyer. However, its declining backlog remains a concern. The 12-month order book declined 2% to $52.8M, while the total backlog fell 5% to $112.9M. We applaud improving gross margin trends, reflecting successful execution of its cost reduction initiatives.

$BLDP